Neonatal severe primary hyperparathyroidism
General Information (adopted from Orphanet):
Synonyms, Signs: |
HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY NSHPT NHPT NSPH |
Number of Symptoms | 38 |
OrphanetNr: | 417 |
OMIM Id: |
239200
|
ICD-10: |
E21.0 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive Not applicable [Orphanet] |
Age of onset: |
Neonatal [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Genetic hyperparathyroidism
-Rare genetic disease Primary bone dysplasia with defective bone mineralization -Rare bone disease -Rare developmental defect during embryogenesis -Rare genetic disease Rare hyperparathyroidism -Rare endocrine disease |
Symptom Information:
|
(HPO:0000121) | Nephrocalcinosis | 57 / 7739 | ||||
|
(HPO:0002150) | Hypercalciuria | 45 / 7739 | ||||
|
(HPO:0003355) | Aminoaciduria | 65 / 7739 | ||||
|
(HPO:0011037) | Decreased urine output | Very frequent [Orphanet] | 47 / 7739 | |||
|
(HPO:0000103) | Polyuria | 60 / 7739 | ||||
|
(HPO:0003109) | Hyperphosphaturia | 18 / 7739 | ||||
|
(HPO:0001959) | Polydipsia | 43 / 7739 | ||||
|
(HPO:0000843) | Hyperparathyroidism | Very frequent [Orphanet] | 17 / 7739 | |||
|
(HPO:0008200) | Primary hyperparathyroidism | 5 / 7739 | ||||
|
(HPO:0003165) | Elevated circulating parathyroid hormone level | 17 / 7739 | ||||
|
(HPO:0002659) | Increased susceptibility to fractures | Very frequent [Orphanet] | 110 / 7739 | |||
|
(HPO:0000774) | Narrow chest | Very frequent [Orphanet] | 167 / 7739 | |||
|
(HPO:0003025) | Metaphyseal irregularity | 42 / 7739 | ||||
|
(HPO:0000944) | Abnormality of the metaphyses | Very frequent [Orphanet] | 141 / 7739 | |||
|
(HPO:0002757) | Recurrent fractures | 47 / 7739 | ||||
|
(HPO:0002240) | Hepatomegaly | Very frequent [Orphanet] | 467 / 7739 | |||
|
(HPO:0002019) | Constipation | 194 / 7739 | ||||
|
(HPO:0008872) | Feeding difficulties in infancy | 153 / 7739 | ||||
|
(HPO:0011968) | Feeding difficulties | 240 / 7739 | ||||
|
(HPO:0001744) | Splenomegaly | Very frequent [Orphanet] | 337 / 7739 | |||
|
(HPO:0004322) | Short stature | Very frequent [Orphanet] | 1232 / 7739 | |||
|
(HPO:0001508) | Failure to thrive | 454 / 7739 | ||||
|
(HPO:0001903) | Anemia | 289 / 7739 | ||||
|
(HPO:0002148) | Hypophosphatemia | 43 / 7739 | ||||
|
(HPO:0004337) | Abnormality of amino acid metabolism | Very frequent [Orphanet] | 45 / 7739 | |||
|
(HPO:0003072) | Hypercalcemia | 36 / 7739 | ||||
|
(HPO:0100530) | Abnormality of calcium-phosphate metabolism | Very frequent [Orphanet] | 12 / 7739 | |||
|
(HPO:0002789) | Tachypnea | 48 / 7739 | ||||
|
(HPO:0002094) | Dyspnea | 132 / 7739 | ||||
|
(HPO:0010547) | Muscle flaccidity | 466 / 7739 | ||||
|
(HPO:0003761) | Calcinosis | 12 / 7739 | ||||
|
(HPO:0008947) | Infantile muscular hypotonia | 482 / 7739 | ||||
|
(HPO:0001252) | Muscular hypotonia | Very frequent [Orphanet] | 990 / 7739 | |||
|
(HPO:0001324) | Muscle weakness | 859 / 7739 | ||||
|
(OMIM) | Demineralization | 1 / 7739 | ||||
|
(OMIM) | Neonatal primary hyperparathyroidism | 1 / 7739 | ||||
|
(OMIM) | Parathyroid chief-cell hyperplasia | 1 / 7739 | ||||
|
(OMIM) | Increased urinary cyclic AMP | 1 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
Neonatal severe hyperparathyroidism usually manifests in the first 6 months of life with severe hypercalcemia, bone demineralization, and failure to thrive. Early diagnosis is critical because untreated NSHPT can be a devastating neurodevelopmental disorder, which in some cases ... |
Clinical Description OMIM |
Hillman et al. (1964) described neonatal hyperparathyroidism, which they described as neonatal primary hyperparathyroidism, in 2 male sibs, offspring of first-cousin parents. Philips (1948) had earlier reported one of the sibs. Goldbloom et al. (1972) observed 2 affected ... |
Molecular genetics OMIM |
Pollak et al. (1993) demonstrated that neonatal severe hyperparathyroidism and familial hypocalciuric hypercalcemia are both due to mutations in the parathyroid Ca(2+)-sensing receptor (see 601199.0001-601199.0003). NSHPT appeared to be caused by homozygous mutations and HCC by heterozygous mutations. ... |